Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lalloo

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Journal of Medical Genetics|November 25, 2003
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programmeE Amir, D G Evans, A Shenton, et al.
Familial Cancer|October 12, 2012
The spectrum of urological malignancy in Lynch syndromeP J Barrow, S Ingham, C O'Hara, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 12, 2005
Surgical decisions made by 158 women with hereditary breast cancer aged <50 yearsD G R Evans, F Lalloo, P Hopwood, et al.
Familial Cancer|May 27, 2010
Breast cancer susceptibility variants alter risk in familial ovarian cancerA Latif, H J McBurney, S A Roberts, et al.
British Journal of Cancer|March 18, 2010
Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 statusD G R Evans, A Moran, R Hartley, et al.
British Journal of Cancer|December 22, 2011
Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older womenL Sidon, S Ingham, T Clancy, et al.
Clinical Genetics|June 24, 2011
Genotype-phenotype correlation in colorectal polyposisK F Newton, E K L Mallinson, J Bowen, et al.
British Journal of Cancer|June 10, 2011
Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRTJ Challberg, L Ashcroft, F Lalloo, et al.
Gut|July 28, 2010
The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposisE K L Mallinson, K F Newton, J Bowen, et al.
Familial Cancer|December 22, 2011
Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutationsA Moran, C O'Hara, S Khan, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal of Medical Genetics|November 25, 2003
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programmeE Amir, D G Evans, A Shenton, et al.
Familial Cancer|October 12, 2012
The spectrum of urological malignancy in Lynch syndromeP J Barrow, S Ingham, C O'Hara, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 12, 2005
Surgical decisions made by 158 women with hereditary breast cancer aged <50 yearsD G R Evans, F Lalloo, P Hopwood, et al.
Familial Cancer|May 27, 2010
Breast cancer susceptibility variants alter risk in familial ovarian cancerA Latif, H J McBurney, S A Roberts, et al.
British Journal of Cancer|March 18, 2010
Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 statusD G R Evans, A Moran, R Hartley, et al.
British Journal of Cancer|December 22, 2011
Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older womenL Sidon, S Ingham, T Clancy, et al.
Clinical Genetics|June 24, 2011
Genotype-phenotype correlation in colorectal polyposisK F Newton, E K L Mallinson, J Bowen, et al.
British Journal of Cancer|June 10, 2011
Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRTJ Challberg, L Ashcroft, F Lalloo, et al.
Gut|July 28, 2010
The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposisE K L Mallinson, K F Newton, J Bowen, et al.
Familial Cancer|December 22, 2011
Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutationsA Moran, C O'Hara, S Khan, et al.
Pageof 7